<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xml:lang="EN" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?origin publisher?><?properties no_embargo?><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlm.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Causes Control</journal-id><journal-title>Cancer Causes &#x00026; Control </journal-title><issn pub-type="ppub">0957-5243</issn><issn pub-type="epub">1573-7225</issn><publisher><publisher-name>Springer Netherlands</publisher-name><publisher-loc>Dordrecht</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">9348</article-id><article-id pub-id-type="doi">10.1007/s10552-009-9348-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Relationship between interferon regulatory factor 4 genetic polymorphisms, measures of sun sensitivity and risk for non-Hodgkin lymphoma</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gathany</surname><given-names>Allison H.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hartge</surname><given-names>Patricia</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Davis</surname><given-names>Scott</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cerhan</surname><given-names>James R.</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Severson</surname><given-names>Richard K.</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cozen</surname><given-names>Wendy</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rothman</surname><given-names>Nathaniel</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Chanock</surname><given-names>Stephen J.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Wang</surname><given-names>Sophia S.</given-names></name><address><phone>+1-301-4025374</phone><fax>+1-301-4020916</fax><email>wangso@mail.nih.gov</email></address><xref ref-type="aff" rid="Aff7">7</xref></contrib><aff id="Aff1"><label>1</label>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 6120 Executive Blvd., Rockville, MD 20852 USA </aff><aff id="Aff2"><label>2</label>Yale School of Public Heath, New Haven, CT USA </aff><aff id="Aff3"><label>3</label>Fred Hutchinson Cancer Research Center and University of Washington, Seattle, WA USA </aff><aff id="Aff4"><label>4</label>Mayo Clinic College of Medicine, Rochester, MN USA </aff><aff id="Aff5"><label>5</label>Karmanos Cancer Institute and Department of Family Medicine, Wayne State University, Detroit, MI USA </aff><aff id="Aff6"><label>6</label>University of Southern California, Los Angeles, CA USA </aff><aff id="Aff7"><label>7</label>Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, 6120 Executive Blvd., EPS 7070, Rockville, MD 20852 USA </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>4</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2009</year></pub-date><volume>20</volume><issue>8</issue><fpage>1291</fpage><lpage>1302</lpage><history><date date-type="received"><day>18</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>7</day><month>4</month><year>2009</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2009</copyright-statement></permissions><abstract xml:lang="EN"><sec><title>Objective</title><p>Sun exposure and sensitivity, including pigmentation, are associated with risk for non-Hodgkin lymphoma (NHL). One variant in the immune regulatory factor 4 (<italic>IRF4</italic>) gene (rs12203592) is associated with pigmentation, and a different <italic>IRF4</italic> variant (rs12211228) is associated with NHL risk. We evaluated the independent roles of these <italic>IRF4</italic> polymorphisms and sun sensitivity in mediating NHL risk and explored whether they are confounded or modified by each other.</p></sec><sec><title>Methods</title><p>Genotyping of tag single nucleotide polymorphisms (SNPs) in the <italic>IRF4</italic> gene was conducted in 990 NHL cases and 828 controls from a multi-center US study. Measures of sun sensitivity and exposure were ascertained from computer-assisted personal interviews. We used logistic regression to compute odds ratios (OR) and 95% confidence intervals (CI) for NHL in relation to sun exposures, sun exposures in relation to <italic>IRF4</italic> genotypes, and NHL in relation to sun exposures. We further assessed the effects of sun exposures in relation to <italic>IRF4</italic> genotypes.</p></sec><sec><title>Results</title><p>As previously reported, we found significant associations between <italic>IRF4</italic> rs12211228 and NHL and between hair and eye color and NHL. The <italic>IRF4</italic> rs12203592 polymorphism (CT/TT genotype) was statistically significantly associated with eye color and particularly with hair color (OR<sub>Light Blonde</sub>&#x000a0;=&#x000a0;0.24, 95% CI&#x000a0;=&#x000a0;0.11&#x02013;0.50, overall Chi square <italic>p</italic>&#x000a0;=&#x000a0;0.0002). Analysis of joint effects between eye and hair color with the <italic>IRF4</italic> rs12203592 SNP did not reveal statistically significant <italic>p</italic>-interactions although NHL risk did decline with lighter hair color and presence of the variant <italic>IRF4</italic> rs12203592 allele, compared to those without a variant allele and with black/brown hair color.</p></sec><sec><title>Conclusions</title><p>Our data do not statistically support a joint effect between <italic>IRF4</italic> and sun sensitivity in mediating risk for NHL. Further evaluation of joint effects in other and larger populations is warranted.</p></sec><sec><title>Electronic supplementary material</title><p>The online version of this article (doi:10.1007/s10552-009-9348-5) contains supplementary material, which is available to authorized users.</p></sec></abstract><kwd-group><title>Keywords</title><kwd>Non-Hodgkin lymphoma</kwd><kwd>Interferon regulatory factor-4</kwd><kwd>Single nucleotide polymorphism</kwd><kwd>Sunlight</kwd><kwd>Pigmentation</kwd></kwd-group><custom-meta-wrap><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Science+Business Media B.V. 2009</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p>Non-Hodgkin lymphomas (NHL) represent a heterogeneous group of cancers arising from lymphocytes for which the etiology remains largely unclear. While the major known risk factor for developing NHL is severe immunodeficiency [<xref ref-type="bibr" rid="CR1">1</xref>], the increased NHL risk among those with a family history of hematopoietic disease [<xref ref-type="bibr" rid="CR2">2</xref>&#x02013;<xref ref-type="bibr" rid="CR5">5</xref>] suggests an important role for genetic susceptibility in NHL etiology. Investigations of germline genetic variation in large epidemiologic case&#x02013;control studies have identified potentially relevant loci that may play a role in modulating risk for NHL [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p><p>A recent pooled analysis of three large population-based NHL case&#x02013;control studies that included the present study found a significant association between a polymorphism in the <italic>IRF4</italic> gene, rs12211228 and NHL risk [<xref ref-type="bibr" rid="CR8">8</xref>]. The <italic>IRF4</italic> gene (also known as <italic>MUM1</italic>) encodes a protein that is a member of the interferon regulatory factor family [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. IRF4 is a B-cell proliferation and differentiation protein essential for class switch recognition and antibody maturation [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>] and is often found abnormally expressed in B cell lymphomas [<xref ref-type="bibr" rid="CR15">15</xref>]. In addition to serving as a marker for lymphoid tumors such as NHL, IRF4 has also been reported to act as a potential marker for melanoma [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p>A recent large genome-wide association study demonstrated a convincing association between a different polymorphism of the <italic>IRF4</italic> gene, rs12203592, and pigmentation phenotypes, most notably hair color [<xref ref-type="bibr" rid="CR17">17</xref>]. This <italic>IRF4</italic> SNP was also shown to be associated with skin color, eye color, and a measure of skin tanning response to sunlight. This report was the first to suggest a link between a particular <italic>IRF4</italic> locus and human pigmentation, though the mechanism for the involvement of this immune regulatory gene in determining hair color and other pigmentation phenotypes remains unclear.</p><p>Interestingly, sun sensitivity and sun exposure have previously been linked with NHL. Hartge et al. [<xref ref-type="bibr" rid="CR18">18</xref>] previously showed a gradient of decreasing NHL risk with increasingly light eye color, one pigmentation phenotype believed to act as a marker of increased sun sensitivity. This relationship between risk for NHL and sun sensitivity and exposure is further supported by recent work from the International Lymphoma Epidemiology Consortium (InterLymph)[<xref ref-type="bibr" rid="CR19">19</xref>], where a pooled analysis of ten case&#x02013;control studies of NHL showed a significant decrease in NHL risk with increasing recreational sun exposure.</p><p>In order to clarify the roles of these two <italic>IRF4</italic> polymorphisms and sun sensitivity in mediating NHL risk and to determine if their respective associations with NHL are confounded or modified by each other, we used a large US multi-center case&#x02013;control study of NHL to evaluate the relationship between <italic>IRF4</italic> polymorphisms and markers of sun sensitivity and sun exposure and their roles in determining risk for non-Hodgkin lymphoma.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Study population</title><p>The study population has been described previously in detail [<xref ref-type="bibr" rid="CR3">3</xref>]. Briefly, we included 1,321 newly diagnosed non-Hodgkin lymphoma cases identified in four Surveillance, Epidemiology, and End Results (SEER) registries (Iowa; Detroit, MI; Los Angeles, CA; and Seattle, WA) between 1 July 1998 and 30 June 2000. Subjects were between the ages of 20 and 74 and had no evidence of HIV infection. A total of 1,057 population controls were identified by random digit dialing (under 65&#x000a0;years old) and from Medicare eligibility files (65&#x000a0;years and older). Overall participation rates were 76% in cases and 52% in controls; overall response rates were 59 and 44%, respectively. Written informed consent was obtained from each participant before interview. This study was approved by the institutional review boards at the NIH and at each participating SEER site (Iowa, Detroit, LA, and Seattle).</p><p>All study participants were asked to provide a venous blood or mouthwash buccal cell sample. We obtained blood samples from 1,172 (89%) cases (773 blood, 399 buccal) and 982 (93%) controls (668 blood, 314 buccal). Genotype frequencies were equivalent for individuals who provided blood compared with buccal cells.</p></sec><sec id="Sec4"><title>Histopathology</title><p>Each SEER registry provided non-Hodgkin lymphoma pathology and subtype information derived from abstracted reports by the local diagnosing pathologist. All cases were histologically confirmed and coded according to the <italic>International Classification of Diseases for Oncology</italic>, <italic>2nd Edition</italic> (ICD-O-2) [<xref ref-type="bibr" rid="CR20">20</xref>] and updated to the World Health Organization classification/ICD-O-3 [<xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec5"><title>Questionnaire data</title><p>The study used a split-sample design to investigate multiple etiologic risk factors in detail without overburdening the participants. A core set of questions was given to all respondents, and the remainder of questions were given to participants in either Group A (all African-American participants and 50% of non-African-American participants) or Group B (50% of non-African-American participants). Prior to the in-person interview, participants were mailed a form for listing residential and job history and either a family and medical history questionnaire (Group A) or a diet and lifestyle questionnaire (Group B). During the home visit, a trained interviewer administered a computer-assisted personal interview (CAPI) that included core questions on demographics, height and weight, occupational history, pesticide exposure, hair color, and hair dye use. The Group A CAPI also included an extended medical history and use of illicit drugs, while the Group B CAPI included an abbreviated medical history, cell phone use, allergies, hobbies, eye color, skin complexion, and sun sensitivity/exposure.</p><p><italic>Sun sensitivity and exposure</italic>. During the interview, we asked participants to estimate how many hours they spent in the sun during the summer in the middle of the day (10:00 AM&#x02013;4:00 PM). We asked separately for weekdays and weekend days and separately for specific periods of their lives including teenage years, twenties, thirties, and the most recent decade. In the analysis, we estimated typical weekly exposure to strong sunlight as a weighted average of weekend and weekday values. We also asked about the use of sun lamps or tanning booths, the typical number of months per year they had a tan, pigmentation characteristics including eye color and skin complexion, and some common measures of skin response to sunlight, including sun rashes and typical reaction to first hour of sun with no tan and no sunburn.</p></sec><sec id="Sec6"><title>DNA extraction and genotyping</title><p>Study participants who did not provide a biologic specimen, did not have sufficient material for DNA extraction or sufficient DNA for genotyping, or whose genotyped sex was discordant from the questionnaire data were excluded from this analysis. As previously described [<xref ref-type="bibr" rid="CR22">22</xref>], DNA was extracted from blood clots or buffy coats (BBI Biotech, Gaithersburg, MD) using Puregene Autopure DNA extraction kits (Gentra Systems, Minneapolis, MN). DNA was extracted from buccal cell samples by phenol&#x02013;chloroform extraction methods [<xref ref-type="bibr" rid="CR23">23</xref>].</p><p>We selected 15 tag single nucleotide polymorphisms (SNPs) in the <italic>IRF4</italic> gene as previously described [<xref ref-type="bibr" rid="CR8">8</xref>]; these included the two <italic>a priori</italic> SNPs of interest&#x02014;rs12211228 and rs12203592. Genotyping was conducted at the National Cancer Institute Core Genotyping Facility (Advanced Technology Center, Gaithersburg, MD) using a custom-designed GoldenGate assay (Illumina, <ext-link ext-link-type="uri" xlink:href="http://www.illumina.com">www.illumina.com</ext-link>). Sequence data and assay conditions are provided at <ext-link ext-link-type="uri" xlink:href="http://snp500cancer.nci.nih.gov">http://snp500cancer.nci.nih.gov</ext-link> [<xref ref-type="bibr" rid="CR24">24</xref>]. SNP completion rates were &#x0003e;95% for the 15 <italic>IRF4</italic> SNPs. Forty replicate samples from two blood donors each and duplicate samples from 100 participants processed in an identical fashion were interspersed for all assays and blinded from the laboratory. The 15 <italic>IRF4</italic> SNPs were &#x0003e;95% concordant in the quality control samples. We excluded samples with a low completion rate (&#x0003c;90%; 11 cases, 6 controls). Hardy&#x02013;Weinberg Equilibrium (HWE) was observed in the control group for all <italic>IRF4</italic> SNPs (assessed separately for non-Hispanic Caucasians and blacks).</p><p>The final analytic population consisted of 990 cases and 828 controls.</p></sec><sec id="Sec7"><title>Statistical analysis</title><p><italic>IRF4 and NHL</italic>. We calculated odds ratios (OR) and 95% confidence intervals (95% CI) as an estimate of relative risk for non-Hodgkin lymphoma outcomes using dichotomous (overall NHL) and polytomous (NHL subtypes) unconditional logistic regression models with the homozygous wild-type genotype as the referent group. We conducted stratified analyses by age (&#x0003c;60 and &#x02265;60&#x000a0;years), sex (male and female), and race (non-Hispanic Caucasians and blacks). Finding no significant differences in the risk estimates by each of these three strata, we pooled the results and adjusted for the study design variables: age (&#x0003c;50, 50&#x02013;59, 60&#x02013;69, 70+), sex, race/ethnicity (non-Hispanic Caucasian, black, other), and study site (Iowa, Los Angeles, Seattle, Detroit). We calculated the <italic>p</italic> for trend based on the three-level ordinal variable (0, 1, 2) of homozygote wild-type, heterozygote, and homozygote variant. In addition to the individual risk estimates for each genotype, we evaluated the dominant model with homozygote wild-type as the referent group for comparison with heterozygotes and homozygote variants combined.</p><p><italic>Sun sensitivity and NHL</italic>. In order to assess the association between the ordinal pigmentation and sun exposure variables and NHL, we calculated the OR and 95% CI using dichotomous and polytomous unconditional logistic regression models for NHL overall and NHL subtypes, respectively. We also calculated the <italic>p</italic> for trend value for linear trend in regression based on the categorical variables (0, 1, 2, etc.) for each level of exposure (e.g., for eye color: dark brown (0), light brown [<xref ref-type="bibr" rid="CR1">1</xref>], hazel (2), blue (3), green/blue-green (4)). For eye and hair color, skin complexion, reaction to first sun of the season, and hours in the mid-day sun in the last 10&#x000a0;years, the category corresponding to the lowest level of sun sensitivity or exposure was used as the referent category. All analyses were conducted both crude and adjusted for the study design variables age, race/ethnicity, sex, and study site. We note that we also included adjustment for education as a surrogate for SES; though education was slightly associated with sunlight exposure, additional adjustment for education did not appreciably alter the risk estimates for NHL (&#x0003c;10%) and we therefore retained the most parsimonious model in our final model which excluded education. Secondary analyses restricted to subjects with genotype data and non-Hispanic Caucasian subjects with genotype data were also performed to assess consistency across population subgroups (adjusted for age, sex, and study site).</p><p><italic>IRF4 and sun sensitivity</italic>. Among controls, we used logistic regression adjusted for age, sex, and study site to model the association between pigmentation or sun exposure and <italic>IRF4</italic> genotypes. For each exposure category, the OR and 95% CI were calculated for the heterozygotes and homozygous variants using the wild-type homozygotes as the referent group. We also calculated the <italic>p</italic> for trend across the genotypes in each exposure category to assess likelihood of that exposure category with each additional minor allele. We also conducted this analysis restricted to non-Hispanic Caucasians in the control group due to known variation in eye color, hair color, and other phenotypic features across race groups.</p><p><italic>Joint effects of IRF4 and sun sensitivity</italic>. For each sun sensitivity exposure, we calculated the OR and 95% CI for NHL using a common referent group and also stratified by <italic>IRF4</italic> genotype under the dominant model, combining heterozygotes and homozygous variants. We calculated the <italic>p</italic>-value for interaction for each exposure and <italic>IRF4</italic> SNP for NHL risk based on the scored variable for each risk factor and for the genotype. In these calculations, we scored the genotype using a two-level categorization to assess risk for the presence of a variant allele. Statistical significance for interaction was evaluated with the Wald test in models that included a product term for the scored risk factor and the scored genotype. The category corresponding to the lowest level of sun sensitivity or sun exposure was used as the referent group for each exposure. Analyses were conducted using SAS version 9.1 (SAS Institute, Cary, NC).</p></sec></sec><sec id="Sec8" sec-type="results"><title>Results</title><p>Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> shows selected characteristics of the NCI-SEER study population. Briefly, the majority of cases and controls were non-Hispanic Caucasians, cases were slightly younger than controls, and there were slightly more men than women in both cases and controls. Cases and controls were distributed roughly evenly into interview groups A and B. The most common NHL subtypes were diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma.<table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Characteristics of NCI-SEER case&#x02013;control study participants</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Characteristic</th><th align="left">Controls</th><th align="left">NHL cases</th></tr><tr><th align="left"/><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="3">SEER registry</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Detroit</td><td char="(" align="char">139 (17)</td><td char="(" align="char">197 (20)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Iowa</td><td char="(" align="char">246 (30)</td><td char="(" align="char">301 (30)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Los Angeles</td><td char="(" align="char">199 (24)</td><td char="(" align="char">234 (24)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Seattle</td><td char="(" align="char">244 (29)</td><td char="(" align="char">258 (26)</td></tr><tr><td align="left" colspan="3">Sex</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Male</td><td char="(" align="char">443 (54)</td><td char="(" align="char">536 (54)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Female</td><td char="(" align="char">385 (47)</td><td char="(" align="char">454 (46)</td></tr><tr><td align="left" colspan="3">Age (years)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;50</td><td char="(" align="char">203 (25)</td><td char="(" align="char">277 (28)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;50&#x02013;59</td><td char="(" align="char">177 (21)</td><td char="(" align="char">235 (24)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;60&#x02013;69</td><td char="(" align="char">285 (34)</td><td char="(" align="char">311 (31)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;70+</td><td char="(" align="char">163 (20)</td><td char="(" align="char">167 (17)</td></tr><tr><td align="left" colspan="3">Race/Ethnicity</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;White, non-Hispanic</td><td char="(" align="char">646 (78)</td><td char="(" align="char">828 (84)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Black</td><td char="(" align="char">112 (14)</td><td char="(" align="char">64 (6)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Asian/other/unknown</td><td char="(" align="char">70 (8)</td><td char="(" align="char">98 (10)</td></tr><tr><td align="left" colspan="3">Education</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;12&#x000a0;years</td><td char="(" align="char">77 (9)</td><td char="(" align="char">98 (10)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;12&#x02013;15&#x000a0;years</td><td char="(" align="char">485 (59)</td><td char="(" align="char">611 (62)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;16+ years</td><td char="(" align="char">266 (32)</td><td char="(" align="char">280 (28)</td></tr><tr><td align="left" colspan="3">NHL histology</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;DLBCL</td><td align="left">&#x02013;</td><td char="(" align="char">294 (30)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Follicular lymphoma</td><td align="left">&#x02013;</td><td char="(" align="char">246 (25)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Marginal zone lymphoma</td><td align="left">&#x02013;</td><td char="(" align="char">82 (8)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;CLL/SLL</td><td align="left">&#x02013;</td><td char="(" align="char">101 (10)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Mantle cell lymphoma</td><td align="left">&#x02013;</td><td char="(" align="char">40 (4)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Lymphoplasmacytic lymphoma</td><td align="left">&#x02013;</td><td char="(" align="char">24 (2)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Burkitt lymphoma</td><td align="left">&#x02013;</td><td char="(" align="char">11 (1)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Mycosis fungoides/S&#x000e9;zary syndrome</td><td align="left">&#x02013;</td><td char="(" align="char">18 (2)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Peripheral T-cell lymphoma</td><td align="left">&#x02013;</td><td char="(" align="char">41 (4)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;NHL, not otherwise specified</td><td align="left">&#x02013;</td><td char="(" align="char">133 (13)</td></tr><tr><td align="left" colspan="3">DNA source</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blood</td><td char="(" align="char">598 (72)</td><td char="(" align="char">688 (69)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Buccal</td><td char="(" align="char">230 (28)</td><td char="(" align="char">302 (31)</td></tr><tr><td align="left" colspan="3">Interview group</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Group A*</td><td char="(" align="char">461 (56)</td><td char="(" align="char">547 (55)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Group B**</td><td char="(" align="char">367 (44)</td><td char="(" align="char">443 (45)</td></tr><tr><td align="left">Total participants</td><td char="(" align="char">828</td><td char="(" align="char">990</td></tr></tbody></table><table-wrap-foot><p><italic>CLL</italic>/<italic>SLL</italic> chronic lymphocytic leukemia/small lymphocytic lymphoma, <italic>DLBCL</italic> diffuse large B-cell lymphoma, <italic>NCI</italic> National Cancer Institute, <italic>NHL</italic> non-Hodgkin lymphoma, <italic>SEER</italic> surveillance, epidemiology, and end results</p><p>* Group A: extended medical history, use of illicit drugs, family medical history in addition to core questions</p><p>** Group B: abbreviated medical history, allergies, hobbies, sun exposure (including eye color and skin complexion), phone use, food frequency questionnaire in addition to core questions</p></table-wrap-foot></table-wrap></p><p><italic>IRF4 and NHL</italic>. Fifteen SNPs in the <italic>IRF4</italic> gene were evaluated for associations with non-Hodgkin lymphoma (Supplementary Table&#x000a0;1). We observed a significant decrease in risk for NHL with the <italic>IRF4</italic> SNP rs12211228 (OR<sub>CG</sub>&#x000a0;=&#x000a0;0.81, 95% CI&#x000a0;=&#x000a0;0.65&#x02013;1.00; OR<sub>CC</sub>&#x000a0;=&#x000a0;0.76, 95% CI&#x000a0;=&#x000a0;0.35&#x02013;1.65; <italic>p</italic>-trend&#x000a0;=&#x000a0;0.04; Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Results were consistent when restricted to non-Hispanic Caucasian subjects. We observed no statistically significant association between the <italic>IRF4</italic> SNP rs12203592 and NHL (Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>). Further, no other <italic>IRF4</italic> SNPs showed a statistically significant association with overall NHL (Supplementary Table&#x000a0;1).<table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Association between selected <italic>IRF4</italic> SNPs and overall risk for non-Hodgkin lymphoma</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3"><italic>IRF4</italic> SNP</th><th align="left" rowspan="3">Genotype</th><th align="left" colspan="4">All subjects</th><th align="left" colspan="4">Non-Hispanic Caucasian subjects</th><th align="left" colspan="4">All subjects in interview Group B<sup>&#x02020;</sup></th></tr><tr><th align="left">Controls</th><th align="left">All NHL</th><th align="left" rowspan="2" colspan="2">OR (95% CI)*</th><th align="left">Controls</th><th align="left">All NHL</th><th align="left" rowspan="2" colspan="2">OR (95% CI)**</th><th align="left">Controls</th><th align="left">All NHL</th><th align="left" rowspan="2" colspan="2">OR (95% CI)*</th></tr><tr><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" rowspan="5">rs12203592</td><td align="left">CC</td><td char="(" align="char">605 (73)</td><td char="(" align="char">730 (74)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">444 (69)</td><td char="(" align="char">588 (71)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">252 (70)</td><td char="(" align="char">307 (71)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td></tr><tr><td align="left">CT</td><td char="(" align="char">202 (24)</td><td char="(" align="char">239 (24)</td><td char="." align="char">0.92</td><td align="left">(0.74, 1.15)</td><td char="(" align="char">182 (28)</td><td char="(" align="char">219 (27)</td><td char="." align="char">0.90</td><td align="left">(0.72, 1.14)</td><td char="(" align="char">98 (27)</td><td char="(" align="char">115 (27)</td><td char="." align="char">0.95</td><td align="left">(0.69, 1.31)</td></tr><tr><td align="left">TT</td><td char="(" align="char">18 (2)</td><td char="(" align="char">19 (2)</td><td char="." align="char">0.81</td><td align="left">(0.42, 1.57)</td><td char="(" align="char">17 (3)</td><td char="(" align="char">19 (2)</td><td char="." align="char">0.85</td><td align="left">(0.43, 1.67)</td><td char="(" align="char">8 (2)</td><td char="(" align="char">9 (2)</td><td char="." align="char">0.96</td><td align="left">(0.36, 2.57)</td></tr><tr><td align="left">CT or TT</td><td char="(" align="char">220 (27)</td><td char="(" align="char">258 (26)</td><td char="." align="char">0.91</td><td align="left">(0.74, 1.13)</td><td char="(" align="char">199 (31)</td><td char="(" align="char">238 (29)</td><td char="." align="char">0.90</td><td align="left">(0.72, 1.13)</td><td char="(" align="char">106 (30)</td><td char="(" align="char">124 (29)</td><td char="." align="char">0.95</td><td align="left">(0.69, 1.30)</td></tr><tr><td align="left"><italic>p</italic>-trend</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.3764</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.3588</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.7572</td></tr><tr><td align="left" rowspan="5">rs12211228</td><td align="left">GG</td><td char="(" align="char">576 (70)</td><td char="(" align="char">724 (73)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">436 (68)</td><td char="(" align="char">588 (71)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">258 (72)</td><td char="(" align="char">305 (71)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td></tr><tr><td align="left">CG</td><td char="(" align="char">236 (29)</td><td char="(" align="char">253 (26)</td><td char="." align="char">0.81</td><td align="left">(0.65, 1.00)</td><td char="(" align="char">196 (30)</td><td char="(" align="char">227 (27)</td><td char="." align="char">0.85</td><td align="left">(0.68, 1.07)</td><td char="(" align="char">96 (27)</td><td char="(" align="char">122 (28)</td><td char="." align="char">1.06</td><td align="left">(0.77, 1.46)</td></tr><tr><td align="left">CC</td><td char="(" align="char">14 (2)</td><td char="(" align="char">13 (1)</td><td char="." align="char">0.76</td><td align="left">(0.35, 1.65)</td><td char="(" align="char">12 (2)</td><td char="(" align="char">13 (2)</td><td char="." align="char">0.88</td><td align="left">(0.40, 1.98)</td><td char="(" align="char">6 (2)</td><td char="(" align="char">5 (1)</td><td char="." align="char">0.81</td><td align="left">(0.24, 2.75)</td></tr><tr><td align="left">CG or CC</td><td char="(" align="char">250 (30)</td><td char="(" align="char">266 (27)</td><td char="." align="char">0.80</td><td align="left">(0.65, 0.99)</td><td char="(" align="char">208 (32)</td><td char="(" align="char">240 (29)</td><td char="." align="char">0.85</td><td align="left">(0.68, 1.07)</td><td char="(" align="char">102 (28)</td><td char="(" align="char">127 (29)</td><td char="." align="char">1.05</td><td align="left">(0.76, 1.43)</td></tr><tr><td align="left"><italic>p</italic>-trend</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.0432</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.1923</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.8636</td></tr></tbody></table><table-wrap-foot><p><italic>CLL</italic>/<italic>SLL</italic> chronic lymphocytic leukemia/small lymphocytic lymphoma, <italic>CI</italic> confidence interval, <italic>DLBCL</italic> diffuse large B-cell lymphoma, <italic>OR</italic> odds ratio, <italic>NHL</italic> non-Hodgkin lymphoma, <italic>SNP</italic> single nucleotide polymorphism</p><p>* Adjusted for age, race/ethnicity, sex, study site</p><p>** Adjusted for age, sex, study site</p><p><sup>&#x02020;</sup>Group B participants have data on eye color, skin complexion, sun exposures, and diet</p></table-wrap-foot></table-wrap></p><p><italic>Sun sensitivity and NHL</italic>. Lighter eye and hair color were both statistically significantly associated with decreased NHL risk (Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>). The associations were more pronounced for eye color than hair color, and both associations were consistent in analyses restricted to participants with <italic>IRF4</italic> genotype data and/or subjects self-reported as non-Hispanic Caucasians. Hours in the mid-day sun in the last 10&#x000a0;years was also associated with decreased NHL risk. Other markers of coloring and sun exposure and sensitivity including skin complexion and reaction to first sun of the season were not associated with NHL risk.<table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Association between pigmentation and sun exposures and overall risk for non-Hodgkin lymphoma</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="3">Exposure</th><th align="left" colspan="3">All subjects</th><th align="left"/><th align="left" colspan="4">All subjects with genotype data</th><th align="left" colspan="4">Non-Hispanic Caucasians w/genotype data</th></tr><tr><th align="left">Controls</th><th align="left">All NHL</th><th align="left" colspan="2">OR (95% CI)*</th><th align="left">Controls</th><th align="left">All NHL</th><th align="left" colspan="2">OR (95% CI)*</th><th align="left">Controls</th><th align="left">All NHL</th><th align="left" colspan="2">OR (95% CI)*</th></tr><tr><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th><th align="left" colspan="2"/><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th><th align="left" colspan="2"/><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th><th align="left" colspan="2"/></tr></thead><tbody><tr><td align="left" colspan="13">Eye color</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dark brown</td><td char="(" align="char">93 (20)</td><td char="(" align="char">158 (29)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">73 (20)</td><td char="(" align="char">121 (28)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">55 (17)</td><td char="(" align="char">96 (24)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light brown</td><td char="(" align="char">41 (9)</td><td char="(" align="char">50 (9)</td><td char="." align="char">0.76</td><td align="left">(0.47, 1.25)</td><td char="(" align="char">32 (9)</td><td char="(" align="char">34 (8)</td><td char="." align="char">0.65</td><td align="left">(0.37, 1.16)</td><td char="(" align="char">23 (7)</td><td char="(" align="char">30 (8)</td><td char="." align="char">0.75</td><td align="left">(0.39, 1.45)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hazel</td><td char="(" align="char">84 (18)</td><td char="(" align="char">96 (17)</td><td char="." align="char">0.64</td><td align="left">(0.43, 0.96)</td><td char="(" align="char">71 (20)</td><td char="(" align="char">73 (17)</td><td char="." align="char">0.61</td><td align="left">(0.39, 0.95)</td><td char="(" align="char">69 (21)</td><td char="(" align="char">69 (17)</td><td char="." align="char">0.57</td><td align="left">(0.35, 0.92)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blue</td><td char="(" align="char">180 (39)</td><td char="(" align="char">188 (34)</td><td char="." align="char">0.60</td><td align="left">(0.42, 0.84)</td><td char="(" align="char">140 (39)</td><td char="(" align="char">155 (36)</td><td char="." align="char">0.66</td><td align="left">(0.45, 0.98)</td><td char="(" align="char">138 (42)</td><td char="(" align="char">153 (39)</td><td char="." align="char">0.65</td><td align="left">(0.43, 0.97)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Green/Blue-green</td><td char="(" align="char">64 (14)</td><td char="(" align="char">59 (11)</td><td char="." align="char">0.49</td><td align="left">(0.31, 0.78)</td><td char="(" align="char">45 (12)</td><td char="(" align="char">49 (11)</td><td char="." align="char">0.61</td><td align="left">(0.36, 1.02)</td><td char="(" align="char">43 (13)</td><td char="(" align="char">47 (12)</td><td char="." align="char">0.59</td><td align="left">(0.34, 1.01)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;<italic>p</italic>-trend</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.0005</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.0378</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.0295</td></tr><tr><td align="left" colspan="13">Hair color</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Black/dark brown</td><td char="(" align="char">462 (44)</td><td char="(" align="char">572 (43)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">354 (43)</td><td char="(" align="char">401 (41)</td><td align="left">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">198 (31)</td><td char="(" align="char">273 (33)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Medium brown</td><td char="(" align="char">223 (21)</td><td char="(" align="char">317 (24)</td><td char="." align="char">1.00</td><td align="left">(0.80, 1.25)</td><td char="(" align="char">177 (21)</td><td char="(" align="char">261 (26)</td><td align="left">1.13</td><td align="left">(0.87, 1.46)</td><td char="(" align="char">162 (25)</td><td char="(" align="char">239 (29)</td><td char="." align="char">1.07</td><td align="left">(0.82, 1.41)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light Brown/dark blonde</td><td char="(" align="char">239 (23)</td><td char="(" align="char">285 (22)</td><td char="." align="char">0.81</td><td align="left">(0.65, 1.02)</td><td char="(" align="char">189 (23)</td><td char="(" align="char">214 (22)</td><td align="left">0.84</td><td align="left">(0.65, 1.09)</td><td char="(" align="char">182 (28)</td><td char="(" align="char">206 (25)</td><td char="." align="char">0.81</td><td align="left">(0.61, 1.06)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light blonde</td><td char="(" align="char">93 (9)</td><td char="(" align="char">86 (7)</td><td char="." align="char">0.62</td><td align="left">(0.45, 0.87)</td><td char="(" align="char">75 (9)</td><td char="(" align="char">66 (7)</td><td align="left">0.65</td><td align="left">(0.45, 0.94)</td><td char="(" align="char">73 (11)</td><td char="(" align="char">64 (8)</td><td char="." align="char">0.63</td><td align="left">(0.43, 0.93)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Red</td><td char="(" align="char">39 (4)</td><td char="(" align="char">58 (4)</td><td char="." align="char">1.02</td><td align="left">(0.66, 1.57)</td><td char="(" align="char">33 (4)</td><td char="(" align="char">47 (5)</td><td align="left">1.05</td><td align="left">(0.65, 1.71)</td><td char="(" align="char">31 (5)</td><td char="(" align="char">46 (6)</td><td char="." align="char">1.05</td><td align="left">(0.64, 1.73)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;<italic>p</italic>-trend</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.0294</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.0870</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.0640</td></tr><tr><td align="left" colspan="13">Skin complexion</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dark</td><td char="(" align="char">20 (4)</td><td char="(" align="char">30 (5)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">18 (5)</td><td char="(" align="char">28 (6)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">15 (5)</td><td char="(" align="char">23 (6)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Medium</td><td char="(" align="char">252 (55)</td><td char="(" align="char">306 (56)</td><td char="." align="char">0.77</td><td align="left">(0.42, 1.41)</td><td char="(" align="char">198 (55)</td><td char="(" align="char">232 (54)</td><td char="." align="char">0.74</td><td align="left">(0.40, 1.40)</td><td char="(" align="char">174 (53)</td><td char="(" align="char">204 (52)</td><td char="." align="char">0.77</td><td align="left">(0.38, 1.53)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light</td><td char="(" align="char">189 (41)</td><td char="(" align="char">215 (39)</td><td char="." align="char">0.69</td><td align="left">(0.37, 1.29)</td><td char="(" align="char">145 (40)</td><td char="(" align="char">172 (40)</td><td char="." align="char">0.72</td><td align="left">(0.38, 1.39)</td><td char="(" align="char">139 (42)</td><td char="(" align="char">168 (43)</td><td char="." align="char">0.74</td><td align="left">(0.37, 1.51)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;<italic>p</italic>-trend</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.2387</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.4904</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.5588</td></tr><tr><td align="left" colspan="13">Reaction to first sun of season</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;No change</td><td char="(" align="char">19 (4)</td><td char="(" align="char">22 (4)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">17 (5)</td><td char="(" align="char">18 (4)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">14 (4)</td><td char="(" align="char">16 (4)</td><td char="(" align="char">1.00</td><td align="left">(Ref.)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Tan w/o burn</td><td char="(" align="char">75 (16)</td><td char="(" align="char">88 (16)</td><td char="." align="char">1.03</td><td align="left">(0.51, 2.06)</td><td char="(" align="char">64 (18)</td><td char="(" align="char">71 (17)</td><td char="." align="char">1.10</td><td align="left">(0.52, 2.33)</td><td char="(" align="char">54 (17)</td><td char="(" align="char">59 (15)</td><td char="(" align="char">1.03</td><td align="left">(0.45, 2.33)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Mild burn to tan</td><td char="(" align="char">200 (44)</td><td char="(" align="char">245 (45)</td><td char="." align="char">1.04</td><td align="left">(0.54, 2.00)</td><td char="(" align="char">152 (42)</td><td char="(" align="char">182 (42)</td><td char="." align="char">1.16</td><td align="left">(0.57, 2.37)</td><td char="(" align="char">137 (42)</td><td char="(" align="char">168 (43)</td><td char="(" align="char">1.14</td><td align="left">(0.53, 2.44)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Burn w/o blisters</td><td char="(" align="char">131 (29)</td><td char="(" align="char">143 (26)</td><td char="." align="char">0.90</td><td align="left">(0.46, 1.77)</td><td char="(" align="char">100 (28)</td><td char="(" align="char">118 (27)</td><td char="." align="char">1.10</td><td align="left">(0.53, 2.29)</td><td char="(" align="char">96 (30)</td><td char="(" align="char">112 (28)</td><td char="(" align="char">1.01</td><td align="left">(0.46, 2.20)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blistering burn</td><td char="(" align="char">34 (7)</td><td char="(" align="char">51 (9)</td><td char="." align="char">1.32</td><td align="left">(0.61, 2.84)</td><td char="(" align="char">25 (7)</td><td char="(" align="char">41 (10)</td><td char="." align="char">1.64</td><td align="left">(0.71, 3.81)</td><td char="(" align="char">24 (7)</td><td char="(" align="char">39 (10)</td><td char="(" align="char">1.52</td><td align="left">(0.62, 3.71)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;<italic>p</italic>-trend</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.8448</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.3468</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.4966</td></tr><tr><td align="left" colspan="13">Hours in mid-day sun (last 10&#x000a0;years)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;7&#x000a0;h/week</td><td char="(" align="char">159 (35)</td><td char="(" align="char">216 (39)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">120 (34)</td><td char="(" align="char">162 (38)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">114 (35)</td><td char="(" align="char">147 (37)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;14&#x000a0;h/week</td><td char="(" align="char">126 (27)</td><td char="(" align="char">145 (26)</td><td char="." align="char">0.84</td><td align="left">(0.61, 1.15)</td><td char="(" align="char">103 (29)</td><td char="(" align="char">115 (27)</td><td char="." align="char">0.82</td><td align="left">(0.57, 1.17)</td><td char="(" align="char">93 (29)</td><td char="(" align="char">107 (27)</td><td char="." align="char">0.89</td><td align="left">(0.61, 1.29)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;28&#x000a0;h/week</td><td char="(" align="char">123 (27)</td><td char="(" align="char">131 (24)</td><td char="." align="char">0.73</td><td align="left">(0.53, 1.02)</td><td char="(" align="char">93 (26)</td><td char="(" align="char">105 (24)</td><td char="." align="char">0.80</td><td align="left">(0.55, 1.16)</td><td char="(" align="char">84 (26)</td><td char="(" align="char">94 (24)</td><td char="." align="char">0.83</td><td align="left">(0.56, 1.23)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;28+&#x000a0;h/week</td><td char="(" align="char">51 (11)</td><td char="(" align="char">59 (11)</td><td char="." align="char">0.73</td><td align="left">(0.46, 1.15)</td><td char="(" align="char">42 (12)</td><td char="(" align="char">50 (12)</td><td char="." align="char">0.77</td><td align="left">(0.47, 1.27)</td><td char="(" align="char">35 (11)</td><td char="(" align="char">47 (12)</td><td char="." align="char">0.92</td><td align="left">(0.54, 1.58)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;<italic>p</italic>-trend</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.0579</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.1982</td><td align="left"/><td align="left"/><td align="left"/><td align="left">0.4924</td></tr></tbody></table><table-wrap-foot><p><italic>CI</italic> confidence interval, <italic>IU</italic> international unit, <italic>NHL</italic> non-Hodgkin lymphoma, <italic>OR</italic> odds ratio</p><p>* Adjusted for age, race/ethnicity, sex, and study site</p><p>** Adjusted for age, sex, and study site</p></table-wrap-foot></table-wrap></p><p><italic>IRF4 and sun sensitivity</italic>. Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref> shows associations between the two <italic>a priori IRF4</italic> SNPs of interest (rs12203592 and rs12211228) and measures of sun sensitivity and sun exposure among non-Hispanic Caucasian population controls. Presence of the variant allele in the <italic>IRF4</italic> SNP rs12203592 was associated with eye color and hair color. The association between hair color and the <italic>IRF4</italic> rs12203592 SNP was most pronounced with increasingly light hair color. Compared to dark brown eyes, the magnitude of association was equivalent for all other eye colors which were strongly associated with the <italic>IRF4</italic> rs12203592 variant allele. Curiously, the association between <italic>IRF4</italic> rs12203592 with hair color and eye color appear to be in opposite directions; this is consistent with the original GWAS results from Han et al. [<xref ref-type="bibr" rid="CR17">17</xref>] though was not further explored.<table-wrap id="Tab4"><label>Table&#x000a0;4</label><caption><p>Association between pigmentation and sun exposures and selected <italic>IRF4</italic> SNPs among non-Hispanic Caucasian controls</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"><italic>IRF4</italic></th><th align="left">CC</th><th align="left" colspan="3">CT</th><th align="left" colspan="3">TT</th><th align="left" colspan="3">CT/TT</th><th align="left">Chi square</th></tr><tr><th align="left">(rs12203592)</th><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th><th align="left" colspan="2">OR (95% CI)*</th><th align="left"><italic>n</italic> (%)</th><th align="left" colspan="2">OR (95% CI)*</th><th align="left"><italic>n</italic> (%)</th><th align="left" colspan="2">OR (95% CI)*</th><th align="left"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" colspan="12">Eye color</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dark brown</td><td char="(" align="char">49 (89)</td><td char="(" align="char">6 (11)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">0 (0)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">6 (11)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light brown</td><td char="(" align="char">16 (70)</td><td char="(" align="char">6 (26)</td><td char="." align="char">4.46</td><td align="left">(1.05, 19.00)</td><td char="(" align="char">1 (4)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">7 (30)</td><td char="." align="char">5.17</td><td align="left">(1.25, 21.35)</td><td align="left">0.0569</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hazel</td><td char="(" align="char">41 (60)</td><td char="(" align="char">26 (38)</td><td char="." align="char">4.71</td><td align="left">(1.69, 13.14)</td><td char="(" align="char">1 (1)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">27 (40)</td><td char="." align="char">4.85</td><td align="left">(1.75, 13.47)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blue</td><td char="(" align="char">89 (65)</td><td char="(" align="char">43 (32)</td><td char="." align="char">4.47</td><td align="left">(1.73, 11.57)</td><td char="(" align="char">4 (3)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">47 (35)</td><td char="." align="char">4.81</td><td align="left">(1.87, 12.36)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Green/blue-green</td><td char="(" align="char">29 (67)</td><td char="(" align="char">13 (30)</td><td char="." align="char">4.68</td><td align="left">(1.29, 17.05)</td><td char="(" align="char">1 (2)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">14 (33)</td><td char="." align="char">4.92</td><td align="left">(1.36, 17.83)</td><td align="left"/></tr><tr><td align="left" colspan="12">Hair color</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Black/dark brown</td><td char="(" align="char">112 (57)</td><td char="(" align="char">77 (39)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">8 (4)</td><td align="left">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">85 (43)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Medium brown</td><td char="(" align="char">107 (66)</td><td char="(" align="char">50 (31)</td><td char="." align="char">0.63</td><td align="left">(0.40, 1.00)</td><td char="(" align="char">4 (2)</td><td align="left">0.53</td><td align="left">(0.15, 1.86)</td><td char="(" align="char">54 (34)</td><td char="." align="char">0.62</td><td align="left">(0.40, 0.97)</td><td align="left">0.0002</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light brown/dark blonde</td><td char="(" align="char">141 (78)</td><td char="(" align="char">37 (20)</td><td char="." align="char">0.35</td><td align="left">(0.22, 0.57)</td><td char="(" align="char">3 (2)</td><td align="left">0.27</td><td align="left">(0.07, 1.08)</td><td char="(" align="char">40 (22)</td><td char="." align="char">0.35</td><td align="left">(0.22, 0.55)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light blonde</td><td char="(" align="char">62 (85)</td><td char="(" align="char">10 (14)</td><td char="." align="char">0.24</td><td align="left">(0.11, 0.50)</td><td char="(" align="char">1 (1)</td><td align="left">0.19</td><td align="left">(0.02, 1.57)</td><td char="(" align="char">11 (15)</td><td char="." align="char">0.23</td><td align="left">(0.11, 0.47)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Red</td><td char="(" align="char">22 (71)</td><td char="(" align="char">8 (26)</td><td char="." align="char">0.55</td><td align="left">(0.22, 1.35)</td><td char="(" align="char">1 (3)</td><td align="left">0.54</td><td align="left">(0.06, 4.83)</td><td char="(" align="char">9 (29)</td><td char="." align="char">0.55</td><td align="left">(0.23, 1.30)</td><td align="left"/></tr><tr><td align="left" colspan="12">Skin complexion</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dark</td><td char="(" align="char">14 (93)</td><td char="(" align="char">1 (7)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">0 (0)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">1 (7)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Medium</td><td char="(" align="char">122 (70)</td><td char="(" align="char">49 (28)</td><td char="." align="char">5.47</td><td align="left">(0.66, 45.23)</td><td char="(" align="char">3 (2)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">52 (30)</td><td char="." align="char">5.76</td><td align="left">(0.70, 47.28)</td><td align="left">0.2223</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light</td><td char="(" align="char">88 (65)</td><td char="(" align="char">44 (32)</td><td char="." align="char">7.25</td><td align="left">(0.88, 60.03)</td><td char="(" align="char">4 (3)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">48 (35)</td><td char="." align="char">7.86</td><td align="left">(0.95, 64.70)</td><td align="left"/></tr><tr><td align="left" colspan="12">Reaction to First Sun of Season</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;No change</td><td char="(" align="char">11 (79)</td><td char="(" align="char">2 (14)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">1 (7)</td><td align="left">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">3 (21)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Tan w/o burn</td><td char="(" align="char">35 (65)</td><td char="(" align="char">18 (33)</td><td char="." align="char">2.38</td><td align="left">(0.38, 14.70)</td><td char="(" align="char">1 (2)</td><td align="left">0.36</td><td align="left">(0.01, 9.85)</td><td char="(" align="char">19 (35)</td><td char="." align="char">1.69</td><td align="left">(0.34, 8.27)</td><td align="left">0.0644</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Mild burn to tan</td><td char="(" align="char">101 (74)</td><td char="(" align="char">34 (25)</td><td char="." align="char">1.45</td><td align="left">(0.28, 7.60)</td><td char="(" align="char">1 (1)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">35 (26)</td><td char="." align="char">0.93</td><td align="left">(0.22, 3.91)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Burn w/o blisters</td><td char="(" align="char">65 (69)</td><td char="(" align="char">26 (28)</td><td char="." align="char">2.36</td><td align="left">(0.43, 13.06)</td><td char="(" align="char">3 (3)</td><td align="left">0.32</td><td align="left">(0.02, 4.85)</td><td char="(" align="char">29 (31)</td><td char="." align="char">1.58</td><td align="left">(0.37, 6.81)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blistering burn</td><td char="(" align="char">10 (42)</td><td char="(" align="char">13 (54)</td><td char="." align="char">8.09</td><td align="left">(1.04, 62.71)</td><td char="(" align="char">1 (4)</td><td align="left">1.25</td><td align="left">(0.05, 28.98)</td><td char="(" align="char">14 (58)</td><td char="." align="char">5.31</td><td align="left">(0.88, 31.89)</td><td align="left"/></tr><tr><td align="left" colspan="12">Hours in mid-day sun (last 10&#x000a0;years)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;7&#x000a0;h/week</td><td char="(" align="char">82 (72)</td><td char="(" align="char">30 (26)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">2 (2)</td><td align="left">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">32 (28)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;14&#x000a0;h/week</td><td char="(" align="char">57 (63)</td><td char="(" align="char">31 (34)</td><td char="." align="char">1.60</td><td align="left">(0.84, 3.02)</td><td char="(" align="char">3 (3)</td><td align="left">2.70</td><td align="left">(0.41, 17.94)</td><td char="(" align="char">34 (37)</td><td char="." align="char">1.66</td><td align="left">(0.90, 3.09)</td><td align="left">0.6797</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;28&#x000a0;h/week</td><td char="(" align="char">61 (73)</td><td char="(" align="char">21 (25)</td><td char="." align="char">0.88</td><td align="left">(0.43, 1.79)</td><td char="(" align="char">1 (1)</td><td align="left">1.09</td><td align="left">(0.09, 12.85)</td><td char="(" align="char">22 (27)</td><td char="." align="char">0.89</td><td align="left">(0.44, 1.78)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;28+&#x000a0;h/week</td><td char="(" align="char">22 (63)</td><td char="(" align="char">12 (34)</td><td char="." align="char">1.62</td><td align="left">(0.61, 4.30)</td><td char="(" align="char">1 (3)</td><td align="left">0.98</td><td align="left">(0.05, 19.91)</td><td char="(" align="char">13 (37)</td><td char="." align="char">1.55</td><td align="left">(0.61, 3.99)</td><td align="left"/></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th align="left"><italic>IRF4</italic></th><th align="left">GG</th><th align="left" colspan="3">CG</th><th align="left" colspan="3">CC</th><th align="left" colspan="3">CG/CC</th><th align="left">Chi square</th></tr><tr><th align="left">(rs12211228)</th><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th><th align="left" colspan="2">OR (95% CI)*</th><th align="left"><italic>n</italic> (%)</th><th align="left" colspan="2">OR (95% CI)*</th><th align="left"><italic>p</italic></th><th align="left" colspan="2">OR (95% CI)*</th><th align="left"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" colspan="12">Eye color</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dark brown</td><td char="(" align="char">44 (80)</td><td char="(" align="char">10 (18)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">1 (2)</td><td align="left">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">11 (20)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light brown</td><td char="(" align="char">15 (65)</td><td char="(" align="char">8 (35)</td><td char="." align="char">2.13</td><td align="left">(0.64, 7.04)</td><td char="(" align="char">0 (0)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">8 (35)</td><td char="." align="char">1.82</td><td align="left">(0.56, 5.88)</td><td align="left">0.7095</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hazel</td><td char="(" align="char">51 (74)</td><td char="(" align="char">17 (25)</td><td char="." align="char">1.46</td><td align="left">(0.58, 3.70)</td><td char="(" align="char">1 (1)</td><td align="left">0.40</td><td align="left">(0.02, 7.52)</td><td char="(" align="char">18 (26)</td><td char="." align="char">1.34</td><td align="left">(0.55, 3.29)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blue</td><td char="(" align="char">96 (70)</td><td char="(" align="char">38 (28)</td><td char="." align="char">1.64</td><td align="left">(0.73, 3.69)</td><td char="(" align="char">4 (3)</td><td align="left">1.68</td><td align="left">(0.18, 15.72)</td><td char="(" align="char">42 (30)</td><td char="." align="char">1.65</td><td align="left">(0.76, 3.58)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Green/blue-green</td><td char="(" align="char">29 (69)</td><td char="(" align="char">13 (31)</td><td char="." align="char">1.83</td><td align="left">(0.64, 5.27)</td><td char="(" align="char">0 (0)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">13 (31)</td><td char="." align="char">1.54</td><td align="left">(0.55, 4.31)</td><td align="left"/></tr><tr><td align="left" colspan="12">Hair color</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Black/dark brown</td><td char="(" align="char">137 (69)</td><td char="(" align="char">55 (28)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">6 (3)</td><td align="left">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">61 (31)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Medium brown</td><td char="(" align="char">102 (63)</td><td char="(" align="char">58 (36)</td><td char="." align="char">1.38</td><td align="left">(0.87, 2.18)</td><td char="(" align="char">2 (1)</td><td align="left">0.48</td><td align="left">(0.09, 2.46)</td><td char="(" align="char">60 (37)</td><td char="." align="char">1.29</td><td align="left">(0.82, 2.02)</td><td align="left">0.4696</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light brown/dark blonde</td><td char="(" align="char">124 (69)</td><td char="(" align="char">54 (30)</td><td char="." align="char">1.15</td><td align="left">(0.73, 1.82)</td><td char="(" align="char">3 (2)</td><td align="left">0.62</td><td align="left">(0.15, 2.56)</td><td char="(" align="char">57 (31)</td><td char="." align="char">1.10</td><td align="left">(0.70, 1.72)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light blonde</td><td char="(" align="char">50 (68)</td><td char="(" align="char">23 (32)</td><td char="." align="char">1.12</td><td align="left">(0.62, 2.05)</td><td char="(" align="char">0 (0)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">23 (32)</td><td char="." align="char">1.03</td><td align="left">(0.57, 1.87)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Red</td><td char="(" align="char">23 (77)</td><td char="(" align="char">6 (20)</td><td char="." align="char">0.59</td><td align="left">(0.22, 1.59)</td><td char="(" align="char">1 (3)</td><td align="left">1.01</td><td align="left">(0.11, 9.48)</td><td char="(" align="char">7 (23)</td><td char="." align="char">0.63</td><td align="left">(0.25, 1.61)</td><td align="left"/></tr><tr><td align="left" colspan="12">Skin complexion</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dark</td><td char="(" align="char">14 (93)</td><td char="(" align="char">1 (7)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">0 (0)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">1 (7)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Medium</td><td char="(" align="char">124 (71)</td><td char="(" align="char">46 (26)</td><td char="." align="char">5.39</td><td align="left">(0.67, 43.48)</td><td char="(" align="char">4 (2)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">50 (29)</td><td char="." align="char">5.74</td><td align="left">(0.71, 46.25)</td><td align="left">0.4045</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light</td><td char="(" align="char">97 (73)</td><td char="(" align="char">39 (28)</td><td char="." align="char">4.19</td><td align="left">(0.48, 36.91)</td><td char="(" align="char">2 (1)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">41 (30)</td><td char="." align="char">4.86</td><td align="left">(0.56, 42.31)</td><td align="left"/></tr><tr><td align="left" colspan="12">Reaction to first sun of season</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;No change</td><td char="(" align="char">12 (86)</td><td char="(" align="char">2 (14)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">0 (0)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">2 (14)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Tan w/o burn</td><td char="(" align="char">41 (76)</td><td char="(" align="char">12 (22)</td><td char="." align="char">1.48</td><td align="left">(0.23, 9.73)</td><td char="(" align="char">1 (2)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">13 (24)</td><td char="." align="char">1.48</td><td align="left">(0.23, 9.73)</td><td align="left">0.7176</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Mild burn to tan</td><td char="(" align="char">102 (74)</td><td char="(" align="char">33 (24)</td><td char="." align="char">1.83</td><td align="left">(0.36, 9.31)</td><td char="(" align="char">2 (1)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">35 (26)</td><td char="." align="char">1.96</td><td align="left">(0.39, 9.90)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Burn w/o blisters</td><td char="(" align="char">64 (67)</td><td char="(" align="char">30 (32)</td><td char="." align="char">2.67</td><td align="left">(0.52, 13.79)</td><td char="(" align="char">1 (1)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">31 (33)</td><td char="." align="char">2.72</td><td align="left">(0.53, 14.05)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blistering burn</td><td char="(" align="char">15 (63)</td><td char="(" align="char">9 (38)</td><td char="." align="char">4.61</td><td align="left">(0.57, 37.05)</td><td char="(" align="char">0 (0)</td><td align="left">&#x02013;</td><td align="left">&#x02013;</td><td char="(" align="char">9 (38)</td><td char="." align="char">4.61</td><td align="left">(0.57, 37.05)</td><td align="left"/></tr><tr><td align="left" colspan="12">Hours in mid-day sun (last 10&#x000a0;years)</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;7&#x000a0;h/week</td><td char="(" align="char">78 (68)</td><td char="(" align="char">34 (30)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">2 (2)</td><td align="left">1.00</td><td align="left">(Ref.)</td><td char="(" align="char">36 (32)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;14&#x000a0;h/week</td><td char="(" align="char">71 (77)</td><td char="(" align="char">19 (21)</td><td char="." align="char">0.63</td><td align="left">(0.33, 1.22)</td><td char="(" align="char">2 (2)</td><td align="left">1.28</td><td align="left">(0.17, 9.67)</td><td char="(" align="char">21 (23)</td><td char="." align="char">0.66</td><td align="left">(0.35, 1.26)</td><td align="left">0.8289</td></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x0003c;28h/week</td><td char="(" align="char">59 (70)</td><td char="(" align="char">24 (29)</td><td char="." align="char">1.16</td><td align="left">(0.58, 2.29)</td><td char="(" align="char">1 (1)</td><td align="left">0.57</td><td align="left">(0.04, 7.83)</td><td char="(" align="char">25 (30)</td><td char="." align="char">1.11</td><td align="left">(0.57, 2.18)</td><td align="left"/></tr><tr><td align="left">&#x000a0;&#x000a0;&#x000a0;&#x000a0;28+&#x000a0;h/week</td><td char="(" align="char">25 (71)</td><td char="(" align="char">9 (26)</td><td char="." align="char">0.99</td><td align="left">(0.37, 2.68)</td><td char="(" align="char">1 (3)</td><td align="left">1.11</td><td align="left">(0.05, 25.05)</td><td char="(" align="char">10 (29)</td><td char="." align="char">1.00</td><td align="left">(0.38, 2.63)</td><td align="left"/></tr></tbody></table><table-wrap-foot><p>Confidence interval <italic>CI</italic>, international unit <italic>IU</italic>, odds ratio <italic>OR</italic>, single nucleotide polymorphism <italic>SNP</italic></p><p>* Adjusted for age, sex, study site</p></table-wrap-foot></table-wrap></p><p>The <italic>IRF4</italic> rs12211228 SNP that was associated with NHL was not statistically significantly associated with any of the measures of sun sensitivity or sun exposure in this study (Table&#x000a0;<xref rid="Tab4" ref-type="table">4</xref>). All results were consistent in analyses expanded beyond non-Hispanic Caucasians and adjusted for race/ethnicity.</p><p>The remaining <italic>IRF4</italic> SNPs evaluated were not found to be statistically significantly associated with measures of sun sensitivity (data not shown).</p><p><italic>Joint effects of IRF4 and sun sensitivity in NHL risk</italic>. Table&#x000a0;<xref rid="Tab5" ref-type="table">5</xref> shows the joint effects between eye and hair color and NHL risk for the two <italic>a priori</italic><italic>IRF4</italic> SNP genotypes. We observed no statistically significant <italic>p</italic>-interactions for either the <italic>IRF4</italic> rs12203592 or rs12211228 SNP with hair color or eye color. However, the risk estimates for NHL among individuals with lighter eye and hair color appeared more pronounced in those with either variant <italic>IRF4</italic> allele than in those with the corresponding common homozygote genotype. This is also observed in stratified analysis (Supplementary Table&#x000a0;2) whereby associations with NHL for eye and hair color appear more pronounced among those with a variant <italic>IRF4</italic> SNP. No joint effects with hair or eye color were observed for the remaining thirteen <italic>IRF4</italic> SNPs evaluated (data not shown).<table-wrap id="Tab5"><label>Table&#x000a0;5</label><caption><p>Joint effects of eye color and hair color (excluding red hair) and overall non-Hodgkin lymphoma risk with <italic>IRF4</italic> genotype, among non-Hispanic Caucasians</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2"><italic>IRF4</italic> SNP</th><th align="left" rowspan="2">Exposure</th><th align="left" rowspan="2">Genotype</th><th align="left">Controls</th><th align="left">All NHL</th><th align="left" rowspan="2" colspan="2">OR (95% CI)*</th><th align="left" rowspan="2"><italic>p</italic>-value</th><th align="left" rowspan="2"><italic>p</italic>-interaction</th></tr><tr><th align="left"><italic>n</italic> (%)</th><th align="left"><italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left">rs12203592</td><td align="left">Eye color</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">0.5475</td></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dark brown</td><td align="left">CC</td><td char="(" align="char">49 (15)</td><td char="(" align="char">79 (20)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/><td align="left"/></tr><tr><td align="left"/><td align="left">CT/TT</td><td char="(" align="char">6 (2)</td><td char="(" align="char">17 (4)</td><td char="." align="char">1.66</td><td align="left">(0.60, 4.55)</td><td char="." align="char">0.3259</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light brown</td><td align="left">CC</td><td char="(" align="char">16 (5)</td><td char="(" align="char">20 (5)</td><td char="." align="char">0.80</td><td align="left">(0.37, 1.71)</td><td char="." align="char">0.5589</td><td align="left"/></tr><tr><td align="left"/><td align="left">CT/TT</td><td char="(" align="char">7 (2)</td><td char="(" align="char">10 (3)</td><td char="." align="char">0.83</td><td align="left">(0.29, 2.37)</td><td char="." align="char">0.7312</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hazel</td><td align="left">CC</td><td char="(" align="char">41 (13)</td><td char="(" align="char">49 (12)</td><td char="." align="char">0.74</td><td align="left">(0.43, 1.29)</td><td char="." align="char">0.2944</td><td align="left"/></tr><tr><td align="left"/><td align="left">CT/TT</td><td char="(" align="char">27 (8)</td><td char="(" align="char">20 (5)</td><td char="." align="char">0.44</td><td align="left">(0.22, 0.88)</td><td char="." align="char">0.0204</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blue</td><td align="left">CC</td><td char="(" align="char">89 (27)</td><td char="(" align="char">99 (25)</td><td char="." align="char">0.69</td><td align="left">(0.44, 1.11)</td><td char="." align="char">0.1241</td><td align="left"/></tr><tr><td align="left"/><td align="left">CT/TT</td><td char="(" align="char">47 (14)</td><td char="(" align="char">54 (14)</td><td char="." align="char">0.71</td><td align="left">(0.41, 1.22)</td><td char="." align="char">0.2118</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Green/blue-green</td><td align="left">CC</td><td char="(" align="char">29 (9)</td><td char="(" align="char">30 (8)</td><td char="." align="char">0.58</td><td align="left">(0.31, 1.11)</td><td char="." align="char">0.0991</td><td align="left"/></tr><tr><td align="left"/><td align="left">CT/TT</td><td char="(" align="char">14 (4)</td><td char="(" align="char">16 (4)</td><td char="." align="char">0.67</td><td align="left">(0.30, 1.52)</td><td char="." align="char">0.3356</td><td align="left"/></tr><tr><td align="left"/><td align="left">Hair color</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">0.6251</td></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Black/dark brown</td><td align="left">CC</td><td char="(" align="char">112 (18)</td><td char="(" align="char">160 (21)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/><td align="left"/></tr><tr><td align="left"/><td align="left">CT/TT</td><td char="(" align="char">85 (14)</td><td char="(" align="char">112 (14)</td><td char="." align="char">0.92</td><td align="left">(0.63, 1.34)</td><td char="." align="char">0.6706</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Medium brown</td><td align="left">CC</td><td char="(" align="char">107 (17)</td><td char="(" align="char">166 (21)</td><td char="." align="char">1.09</td><td align="left">(0.77, 1.54)</td><td char="." align="char">0.6402</td><td align="left"/></tr><tr><td align="left"/><td align="left">CT/TT</td><td char="(" align="char">54 (9)</td><td char="(" align="char">72 (9)</td><td char="." align="char">0.94</td><td align="left">(0.61, 1.45)</td><td char="." align="char">0.7721</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light brown/dark blonde</td><td align="left">CC</td><td char="(" align="char">141 (23)</td><td char="(" align="char">174 (22)</td><td char="." align="char">0.85</td><td align="left">(0.61, 1.18)</td><td char="." align="char">0.3330</td><td align="left"/></tr><tr><td align="left"/><td align="left">CT/TT</td><td char="(" align="char">40 (7)</td><td char="(" align="char">32 (4)</td><td char="." align="char">0.55</td><td align="left">(0.32, 0.94)</td><td char="." align="char">0.0282</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light blonde</td><td align="left">CC</td><td char="(" align="char">62 (10)</td><td char="(" align="char">58 (7)</td><td char="." align="char">0.65</td><td align="left">(0.42, 1.01)</td><td char="." align="char">0.0546</td><td align="left"/></tr><tr><td align="left"/><td align="left">CT/TT</td><td char="(" align="char">11 (2)</td><td char="(" align="char">6 (1)</td><td char="." align="char">0.36</td><td align="left">(0.13, 1.00)</td><td char="." align="char">0.0496</td><td align="left"/></tr><tr><td align="left">rs12211228</td><td align="left">Eye color</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">0.5878</td></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Dark brown</td><td align="left">GG</td><td char="(" align="char">44 (13)</td><td char="(" align="char">67 (17)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/><td align="left"/></tr><tr><td align="left"/><td align="left">CG/CC</td><td char="(" align="char">11 (3)</td><td char="(" align="char">29 (7)</td><td char="." align="char">1.69</td><td align="left">(0.76, 3.77)</td><td char="." align="char">0.2011</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light brown</td><td align="left">GG</td><td char="(" align="char">15 (5)</td><td char="(" align="char">23 (6)</td><td char="." align="char">1.04</td><td align="left">(0.48, 2.25)</td><td char="." align="char">0.9121</td><td align="left"/></tr><tr><td align="left"/><td align="left">CG/GG</td><td char="(" align="char">8 (2)</td><td char="(" align="char">7 (2)</td><td char="." align="char">0.54</td><td align="left">(0.18, 1.63)</td><td char="." align="char">0.2710</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Hazel</td><td align="left">GG</td><td char="(" align="char">51 (16)</td><td char="(" align="char">49 (12)</td><td char="." align="char">0.62</td><td align="left">(0.36, 1.09)</td><td char="." align="char">0.0946</td><td align="left"/></tr><tr><td align="left"/><td align="left">CG/GG</td><td char="(" align="char">18 (6)</td><td char="(" align="char">20 (5)</td><td char="." align="char">0.73</td><td align="left">(0.34, 1.55)</td><td char="." align="char">0.4098</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Blue</td><td align="left">GG</td><td char="(" align="char">96 (29)</td><td char="(" align="char">105 (27)</td><td char="." align="char">0.73</td><td align="left">(0.45, 1.18)</td><td char="." align="char">0.1951</td><td align="left"/></tr><tr><td align="left"/><td align="left">CG/GG</td><td char="(" align="char">42 (13)</td><td char="(" align="char">48 (12)</td><td char="." align="char">0.76</td><td align="left">(0.43, 1.35)</td><td char="." align="char">0.3501</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Green/blue-green</td><td align="left">GG</td><td char="(" align="char">29 (9)</td><td char="(" align="char">34 (9)</td><td char="." align="char">0.71</td><td align="left">(0.38, 1.35)</td><td char="." align="char">0.3008</td><td align="left"/></tr><tr><td align="left"/><td align="left">CG/GG</td><td char="(" align="char">13 (4)</td><td char="(" align="char">13 (3)</td><td char="." align="char">0.64</td><td align="left">(0.27, 1.52)</td><td char="." align="char">0.3096</td><td align="left"/></tr><tr><td align="left"/><td align="left">Hair color</td><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left"/><td align="left">0.3200</td></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Black/dark brown</td><td align="left">GG</td><td char="(" align="char">137 (22)</td><td char="(" align="char">187 (24)</td><td char="." align="char">1.00</td><td align="left">(Ref.)</td><td align="left"/><td align="left"/></tr><tr><td align="left"/><td align="left">CG/GG</td><td char="(" align="char">61 (10)</td><td char="(" align="char">86 (11)</td><td char="." align="char">1.03</td><td align="left">(0.69, 1.54)</td><td char="." align="char">0.8772</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Medium Brown</td><td align="left">GG</td><td char="(" align="char">102 (17)</td><td char="(" align="char">176 (23)</td><td char="." align="char">1.27</td><td align="left">(0.91, 1.78)</td><td char="." align="char">0.1550</td><td align="left"/></tr><tr><td align="left"/><td align="left">CG/GG</td><td char="(" align="char">60 (10)</td><td char="(" align="char">63 (8)</td><td char="." align="char">0.76</td><td align="left">(0.50, 1.16)</td><td char="." align="char">0.2007</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light brown/dark blonde</td><td align="left">GG</td><td char="(" align="char">124 (20)</td><td char="(" align="char">146 (19)</td><td char="." align="char">0.85</td><td align="left">(0.61, 1.18)</td><td char="." align="char">0.3219</td><td align="left"/></tr><tr><td align="left"/><td align="left">CG/GG</td><td char="(" align="char">57 (9)</td><td char="(" align="char">60 (8)</td><td char="." align="char">0.76</td><td align="left">(0.49, 1.17)</td><td char="." align="char">0.2066</td><td align="left"/></tr><tr><td align="left"/><td align="left" rowspan="2">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Light blonde</td><td align="left">GG</td><td char="(" align="char">50 (8)</td><td char="(" align="char">46 (6)</td><td char="." align="char">0.65</td><td align="left">(0.41, 1.04)</td><td char="." align="char">0.0727</td><td align="left"/></tr><tr><td align="left"/><td align="left">CG/GG</td><td char="(" align="char">23 (4)</td><td char="(" align="char">18 (2)</td><td char="." align="char">0.58</td><td align="left">(0.30, 1.13)</td><td char="." align="char">0.1094</td><td align="left"/></tr></tbody></table><table-wrap-foot><p><italic>CI</italic> Confidence interval, <italic>NHL</italic> non-Hodgkin lymphoma, <italic>OR</italic> odds ratio, <italic>SNP</italic> single nucleotide polymorphism</p><p>* Adjusted for age, sex, and study center</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9" sec-type="discussion"><title>Discussion</title><p>The independent associations observed in our data are consistent with those previously published for sun sensitivity and NHL [<xref ref-type="bibr" rid="CR19">19</xref>], for <italic>IRF4</italic> rs12203592 and hair color [<xref ref-type="bibr" rid="CR17">17</xref>], and for <italic>IRF4</italic> rs12211228 and NHL [<xref ref-type="bibr" rid="CR8">8</xref>], to which our data contributed. Of note, the <italic>IRF4</italic> rs12203592 SNP associated with hair color was not associated with NHL, and the <italic>IRF4</italic> rs12211228 SNP associated with NHL was not associated with hair color. The two <italic>IRF4</italic> SNPs are neither correlated nor in linkage disequilibrium with one another (<italic>r</italic><sup>2</sup>=0.001, D&#x02019;=0.04), and accordingly we found no statistically significant <italic>p</italic>-interactions between <italic>IRF4</italic> SNPs, measures of sun sensitivity such as hair color, and NHL risk. We do note that although associations between hair color and NHL risk were observed among those with and without variant <italic>IRF4</italic> rs12203592 or rs12211228 alleles, the risk estimates were slightly more pronounced among those with either variant <italic>IRF4</italic> genotype. We, therefore, cannot discount a possible interrelationship between the <italic>IRF4</italic> SNPs with sun sensitivity and NHL risk given our relatively small sample size to evaluate joint effects. We believe that further evaluation, such as in consortial settings where adequate sample sizes are available to assess joint effects, are needed to determine whether these two pathways both function through immune mediation or separately with one through immune mediation and one through pigmentation.</p><p>The major strengths of this study include the use of population-based selection for both cases and controls and the ascertainment of data on a range of measures designed to assess sun sensitivity and sun exposure in study subjects. Also, our study population reflects all three previously reported independent associations at the basis of this analysis, making it ideal for investigating potential joint effects. Study limitations include lower sample sizes available for some primary and secondary analyses resulting from the split-sample design, which allowed for the collection of sun exposure and sun sensitivity data in only half of the participant pool. This decreased the study&#x02019;s power to detect significant interactions. Additionally, the relatively low participation and response rates for the study increase the potential for selection bias in the sample.</p><p>We acknowledge that our data may not have detected a joint effect because none existed, because of limited sample size and power to detect a joint effect, or because of our imperfect measures for both genotype and sun exposures, which may have biased our results toward the null. The <italic>IRF4</italic> SNPs associated with NHL and hair color were originally identified as part of a tagging algorithm and thus are considered markers of susceptibility. The SNPs evaluated are thus surrogates and likely in linkage disequilibrium with the causal SNP. In addition, the specific mechanism by which sun sensitivity and sun exposure affects NHL risk is unknown and the pigmentation phenotypes such as hair color are considered surrogates for this measure. We, therefore, cannot exclude the possibility that our null observations for joint effects between <italic>IRF4</italic> and sun sensitivity are due to our having a poor surrogate marker for the causal factor(s). Finally, we also cannot exclude the possibility that joint effects may exist for specific NHL subtypes which we were unable to evaluate due to small numbers in our study.</p><p>In summary, our data support that genetic polymorphisms in the immune regulatory gene <italic>IRF4</italic> are linked to both risk for non-Hodgkin lymphoma and to hair color and other phenotypic measures of sun sensitivity and exposure. Further evaluation of joint effects in independent and larger populations is needed. If joint effects are shown, further investigations to identify the mechanisms by which sun sensitivity or exposure and <italic>IRF4</italic> genes function to modulate risk for NHL are warranted.</p></sec><sec sec-type="supplementary-material"><title>Electronic supplementary material</title><supplementary-material id="N0x1cb2cb0N0x2e41a08" content-type="local-data"><p>Below is the link to the electronic supplementary material.</p><media xlink:href="10552_2009_9348_MOESM1_ESM.pdf" id="MOESM1" mimetype="application" mime-subtype="pdf"><caption><p>(PDF 112&#x000a0;kb)</p></caption></media><media xlink:href="10552_2009_9348_MOESM2_ESM.pdf" mimetype="application" mime-subtype="pdf"><caption><p>(PDF 69&#x000a0;kb)</p></caption></media></supplementary-material></sec></body><back><ack><p>We gratefully acknowledge the staff and scientists at the SEER centers in Iowa, Los Angeles, Detroit, and Seattle for conducting the study&#x02019;s fieldwork and collection of biological specimens. We also thank Peter Hui of Information Management Services, Inc. for his programming support. This research was supported by the Intramural Research Program (IRP) of the NIH, National Cancer Institute. Financial support was provided by Public Health Service (PHS) contracts: N01-PC-65064, N01-PC-67008, N01-PC-67009, N01-PC-67010, N01-OC-71105<italic>.</italic></p><p><bold>Open Access</bold> This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.</p></ack><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Hartge</surname><given-names>P</given-names></name><name><surname>Bracci</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Schottenfeld</surname><given-names>D</given-names></name><name><surname>Fraumeni</surname><given-names>J</given-names><suffix>Jr</suffix></name></person-group><article-title>Non-Hodgkin lymphoma</article-title><source>Cancer epidemiology and prevention</source><year>2006</year><publisher-loc>Oxford</publisher-loc><publisher-name>Oxford Press</publisher-name></citation><citation citation-type="display-unstructured">Hartge P, Bracci P, Wang S (2006) Non-Hodgkin lymphoma. In: Schottenfeld D, Fraumeni J Jr (eds) Cancer epidemiology and prevention. Oxford Press, Oxford </citation></ref><ref id="CR2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>E</given-names></name><name><surname>Smedby</surname><given-names>K</given-names></name><name><surname>Hjalgrim</surname><given-names>H</given-names></name><etal/></person-group><article-title>Family history of hematopoietic malignancy and risk of lymphoma</article-title><source>J Natl Cancer Inst</source><year>2005</year><volume>97</volume><issue>19</issue><fpage>1466</fpage><lpage>1474</lpage></citation><citation citation-type="display-unstructured">Chang E, Smedby K, Hjalgrim H et al (2005) Family history of hematopoietic malignancy and risk of lymphoma. J Natl Cancer Inst 97(19):1466&#x02013;1474 <pub-id pub-id-type="pmid">16204696</pub-id></citation></ref><ref id="CR3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chatterjee</surname><given-names>N</given-names></name><name><surname>Hartge</surname><given-names>P</given-names></name><name><surname>Cerhan</surname><given-names>J</given-names></name><etal/></person-group><article-title>Risk of non-Hodgkin&#x02019;s lymphoma and family history of lymphatic, hematologic, and other cancers</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2004</year><volume>13</volume><issue>9</issue><fpage>1415</fpage><lpage>1421</lpage></citation><citation citation-type="display-unstructured">Chatterjee N, Hartge P, Cerhan J et al (2004) Risk of non-Hodgkin&#x02019;s lymphoma and family history of lymphatic, hematologic, and other cancers. Cancer Epidemiol Biomarkers Prev 13(9):1415&#x02013;1421 <pub-id pub-id-type="pmid">15342441</pub-id></citation></ref><ref id="CR4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goldgar</surname><given-names>D</given-names></name><name><surname>Easton</surname><given-names>D</given-names></name><name><surname>Cannon-Albright</surname><given-names>L</given-names></name><name><surname>Skolnick</surname><given-names>M</given-names></name></person-group><article-title>Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands</article-title><source>J Natl Cancer Inst</source><year>1994</year><volume>86</volume><issue>21</issue><fpage>1600</fpage><lpage>1608</lpage><pub-id pub-id-type="doi">10.1093/jnci/86.21.1600</pub-id></citation><citation citation-type="display-unstructured">Goldgar D, Easton D, Cannon-Albright L, Skolnick M (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86(21):1600&#x02013;1608. doi:10.1093/jnci/86.21.1600 <pub-id pub-id-type="pmid">7932824</pub-id></citation></ref><ref id="CR5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Slager</surname><given-names>S</given-names></name><name><surname>Brennan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph)</article-title><source>Blood</source><year>2007</year><volume>109</volume><issue>8</issue><fpage>3479</fpage><lpage>3488</lpage><pub-id pub-id-type="doi">10.1182/blood-2006-06-031948</pub-id></citation><citation citation-type="display-unstructured">Wang S, Slager S, Brennan P et al (2007) Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 109(8):3479&#x02013;3488. doi:10.1182/blood-2006-06-031948 <pub-id pub-id-type="pmid">17185468</pub-id></citation></ref><ref id="CR6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rothman</surname><given-names>N</given-names></name><name><surname>Skibola</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium</article-title><source>Lancet Oncol</source><year>2006</year><volume>7</volume><issue>1</issue><fpage>27</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1016/S1470-2045(05)70434-4</pub-id></citation><citation citation-type="display-unstructured">Rothman N, Skibola C, Wang S et al (2006) Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol 7(1):27&#x02013;38. doi:10.1016/S1470-2045(05)70434-4 <pub-id pub-id-type="pmid">16389181</pub-id></citation></ref><ref id="CR7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skibola</surname><given-names>C</given-names></name><name><surname>Curry</surname><given-names>J</given-names></name><name><surname>Nieters</surname><given-names>A</given-names></name></person-group><article-title>Genetic susceptibility to lymphoma</article-title><source>Haematologica</source><year>2007</year><volume>92</volume><issue>7</issue><fpage>960</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.3324/haematol.11011</pub-id></citation><citation citation-type="display-unstructured">Skibola C, Curry J, Nieters A (2007) Genetic susceptibility to lymphoma. Haematologica 92(7):960&#x02013;969. doi:10.3324/haematol.11011 <pub-id pub-id-type="pmid">17606447</pub-id></citation></ref><ref id="CR8"><label>8.</label><citation citation-type="other">Wang S, Purdue M, Cerhan J et al. (2009) Common genetic variations in the tumor necrosis factor (TNF) and TNF receptor superfamilies and nuclear factor kappa beta transcription factors and risk of non-Hodgkin lymphoma. Plos One (in press)</citation></ref><ref id="CR9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eisenbeis</surname><given-names>C</given-names></name><name><surname>Singh</surname><given-names>H</given-names></name><name><surname>Storb</surname><given-names>U</given-names></name></person-group><article-title>Pip, a novel IRF family member is a lymphoid-specific, PU.1-dependent transcriptional activator</article-title><source>Genes Dev</source><year>1995</year><volume>9</volume><issue>11</issue><fpage>1377</fpage><lpage>1387</lpage><pub-id pub-id-type="doi">10.1101/gad.9.11.1377</pub-id></citation><citation citation-type="display-unstructured">Eisenbeis C, Singh H, Storb U (1995) Pip, a novel IRF family member is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 9(11):1377&#x02013;1387. doi:10.1101/gad.9.11.1377 <pub-id pub-id-type="pmid">7797077</pub-id></citation></ref><ref id="CR10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grossman</surname><given-names>A</given-names></name><name><surname>Mittr&#x000fc;cker</surname><given-names>H</given-names></name><name><surname>Nicholl</surname><given-names>J</given-names></name><etal/></person-group><article-title>Cloning of human lymphocyte-specific interferon regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23&#x02013;p25</article-title><source>Genomics</source><year>1996</year><volume>37</volume><issue>2</issue><fpage>229</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1006/geno.1996.0547</pub-id></citation><citation citation-type="display-unstructured">Grossman A, Mittr&#x000fc;cker H, Nicholl J et al (1996) Cloning of human lymphocyte-specific interferon regulatory factor (hLSIRF/hIRF4) and mapping of the gene to 6p23&#x02013;p25. Genomics 37(2):229&#x02013;233. doi:10.1006/geno.1996.0547 <pub-id pub-id-type="pmid">8921401</pub-id></citation></ref><ref id="CR11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsuyama</surname><given-names>T</given-names></name><name><surname>Grossman</surname><given-names>A</given-names></name><name><surname>Mittr&#x000fc;cker</surname><given-names>H</given-names></name><etal/></person-group><article-title>Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE)</article-title><source>Nucleic Acids Res</source><year>1995</year><volume>23</volume><issue>12</issue><fpage>2127</fpage><lpage>2136</lpage><pub-id pub-id-type="doi">10.1093/nar/23.12.2127</pub-id></citation><citation citation-type="display-unstructured">Matsuyama T, Grossman A, Mittr&#x000fc;cker H et al (1995) Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res 23(12):2127&#x02013;2136. doi:10.1093/nar/23.12.2127 <pub-id pub-id-type="pmid">7541907</pub-id></citation></ref><ref id="CR12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamagata</surname><given-names>T</given-names></name><name><surname>Nishida</surname><given-names>J</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><etal/></person-group><article-title>A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes</article-title><source>Mol Cell Biol</source><year>1996</year><volume>16</volume><issue>4</issue><fpage>1283</fpage><lpage>1294</lpage></citation><citation citation-type="display-unstructured">Yamagata T, Nishida J, Tanaka S et al (1996) A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol 16(4):1283&#x02013;1294 <pub-id pub-id-type="pmid">8657101</pub-id></citation></ref><ref id="CR13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fillatreau</surname><given-names>S</given-names></name><name><surname>Radbruch</surname><given-names>A</given-names></name></person-group><article-title>IRF4&#x02014;a factor for class switching and antibody secretion</article-title><source>Nat Immunol</source><year>2006</year><volume>7</volume><issue>7</issue><fpage>704</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1038/ni0706-704</pub-id></citation><citation citation-type="display-unstructured">Fillatreau S, Radbruch A (2006) IRF4&#x02014;a factor for class switching and antibody secretion. Nat Immunol 7(7):704&#x02013;706. doi:10.1038/ni0706-704 <pub-id pub-id-type="pmid">16785887</pub-id></citation></ref><ref id="CR14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>U</given-names></name><name><surname>Casola</surname><given-names>S</given-names></name><name><surname>Cattoretti</surname><given-names>G</given-names></name><etal/></person-group><article-title>Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination</article-title><source>Nat Immunol</source><year>2006</year><volume>7</volume><issue>7</issue><fpage>773</fpage><lpage>782</lpage><pub-id pub-id-type="doi">10.1038/ni1357</pub-id></citation><citation citation-type="display-unstructured">Klein U, Casola S, Cattoretti G et al (2006) Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 7(7):773&#x02013;782. doi:10.1038/ni1357 <pub-id pub-id-type="pmid">16767092</pub-id></citation></ref><ref id="CR15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Falini</surname><given-names>B</given-names></name><name><surname>Fizzotti</surname><given-names>M</given-names></name><name><surname>Pucciarini</surname><given-names>A</given-names></name><etal/></person-group><article-title>A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells</article-title><source>Blood</source><year>2000</year><volume>95</volume><issue>6</issue><fpage>2084</fpage><lpage>2092</lpage></citation><citation citation-type="display-unstructured">Falini B, Fizzotti M, Pucciarini A et al (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 95(6):2084&#x02013;2092 <pub-id pub-id-type="pmid">10706878</pub-id></citation></ref><ref id="CR16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sundram</surname><given-names>U</given-names></name><name><surname>Harvell</surname><given-names>J</given-names></name><name><surname>Rouse</surname><given-names>R</given-names></name><name><surname>Natkunam</surname><given-names>Y</given-names></name></person-group><article-title>Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA</article-title><source>Mod Pathol</source><year>2003</year><volume>16</volume><issue>8</issue><fpage>802</fpage><lpage>810</lpage><pub-id pub-id-type="doi">10.1097/01.MP.0000081726.49886.CF</pub-id></citation><citation citation-type="display-unstructured">Sundram U, Harvell J, Rouse R, Natkunam Y (2003) Expression of the B-cell proliferation marker MUM1 by melanocytic lesions and comparison with S100, gp100 (HMB45), and MelanA. Mod Pathol 16(8):802&#x02013;810. doi:10.1097/01.MP.0000081726.49886.CF <pub-id pub-id-type="pmid">12920225</pub-id></citation></ref><ref id="CR17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Nan</surname><given-names>H</given-names></name><etal/></person-group><article-title>A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation</article-title><source>PLoS Genet</source><year>2008</year><volume>4</volume><issue>5</issue><fpage>e1000074</fpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1000074</pub-id></citation><citation citation-type="display-unstructured">Han J, Kraft P, Nan H et al (2008) A genome-wide association study identifies novel alleles associated with hair color and skin pigmentation. PLoS Genet 4(5):e1000074. doi:10.1371/journal.pgen.1000074 <pub-id pub-id-type="pmid">18483556</pub-id></citation></ref><ref id="CR18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hartge</surname><given-names>P</given-names></name><name><surname>Lim</surname><given-names>U</given-names></name><name><surname>Freedman</surname><given-names>D</given-names></name><etal/></person-group><article-title>Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States)</article-title><source>Cancer Causes Control</source><year>2006</year><volume>17</volume><issue>8</issue><fpage>1045</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1007/s10552-006-0040-8</pub-id></citation><citation citation-type="display-unstructured">Hartge P, Lim U, Freedman D et al (2006) Ultraviolet radiation, dietary vitamin D, and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 17(8):1045&#x02013;1052. doi:10.1007/s10552-006-0040-8 <pub-id pub-id-type="pmid">16933055</pub-id></citation></ref><ref id="CR19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kricker</surname><given-names>A</given-names></name><name><surname>Armstrong</surname><given-names>B</given-names></name><name><surname>Hughes</surname><given-names>A</given-names></name><etal/></person-group><article-title>Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium</article-title><source>Int J Cancer</source><year>2008</year><volume>122</volume><issue>1</issue><fpage>144</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1002/ijc.23003</pub-id></citation><citation citation-type="display-unstructured">Kricker A, Armstrong B, Hughes A et al (2008) Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 122(1):144&#x02013;154. doi:10.1002/ijc.23003 <pub-id pub-id-type="pmid">17708556</pub-id></citation></ref><ref id="CR20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>N</given-names></name><name><surname>Jaffe</surname><given-names>E</given-names></name><name><surname>Stein</surname><given-names>H</given-names></name><etal/></person-group><article-title>A revised European&#x02013;American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group</article-title><source>Blood</source><year>1994</year><volume>84</volume><issue>5</issue><fpage>1361</fpage><lpage>1392</lpage></citation><citation citation-type="display-unstructured">Harris N, Jaffe E, Stein H et al (1994) A revised European&#x02013;American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84(5):1361&#x02013;1392 <pub-id pub-id-type="pmid">8068936</pub-id></citation></ref><ref id="CR21"><label>21.</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Jaffe</surname><given-names>ES</given-names></name><name><surname>Harris</surname><given-names>NL</given-names></name><name><surname>Stein</surname><given-names>H</given-names></name><name><surname>Vardiman</surname><given-names>JW</given-names></name></person-group><source>Pathology and genetics of tumours of haematopoietic and lymphoid tissues</source><year>2001</year><publisher-loc>Lyon</publisher-loc><publisher-name>IARC Press</publisher-name></citation><citation citation-type="display-unstructured">Jaffe ES, Harris NL, Stein H, Vardiman JW (2001) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon </citation></ref><ref id="CR22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Cerhan</surname><given-names>J</given-names></name><name><surname>Hartge</surname><given-names>P</given-names></name><etal/></person-group><article-title>Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma</article-title><source>Cancer Res</source><year>2006</year><volume>66</volume><issue>19</issue><fpage>9771</fpage><lpage>9780</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-0324</pub-id></citation><citation citation-type="display-unstructured">Wang S, Cerhan J, Hartge P et al (2006) Common genetic variants in proinflammatory and other immunoregulatory genes and risk for non-Hodgkin lymphoma. Cancer Res 66(19):9771&#x02013;9780. doi:10.1158/0008-5472.CAN-06-0324 <pub-id pub-id-type="pmid">17018637</pub-id></citation></ref><ref id="CR23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Closas</surname><given-names>M</given-names></name><name><surname>Egan</surname><given-names>K</given-names></name><name><surname>Abruzzo</surname><given-names>J</given-names></name><etal/></person-group><article-title>Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash</article-title><source>Cancer Epidemiol Biomarkers Prev</source><year>2001</year><volume>10</volume><issue>6</issue><fpage>687</fpage><lpage>696</lpage></citation><citation citation-type="display-unstructured">Garc&#x000ed;a-Closas M, Egan K, Abruzzo J et al (2001) Collection of genomic DNA from adults in epidemiological studies by buccal cytobrush and mouthwash. Cancer Epidemiol Biomarkers Prev 10(6):687&#x02013;696 <pub-id pub-id-type="pmid">11401920</pub-id></citation></ref><ref id="CR24"><label>24.</label><citation citation-type="other">Packer B, Yeager M, Staats B, et al. (2004) SNP500 Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes. Nucleic Acids Res. 32(Database issue):D528-32. doi:10.1093/nar/gkh005</citation></ref></ref-list><glossary><title>Abbreviations</title><def-list><def-item><term>CAPI</term><def><p>Computer-assisted personal interview</p></def></def-item><def-item><term>CI</term><def><p>Confidence interval</p></def></def-item><def-item><term>CLL/SLL</term><def><p>Chronic lymphocytic leukemia/small lymphocytic lymphoma</p></def></def-item><def-item><term>DLBCL</term><def><p>Diffuse large B-cell lymphoma</p></def></def-item><def-item><term>HHHQ</term><def><p>Health habits and history questionnaire</p></def></def-item><def-item><term>HWE</term><def><p>Hardy&#x02013;Weinberg equilibrium</p></def></def-item><def-item><term>ICD-O</term><def><p>International classification of diseases for oncology</p></def></def-item><def-item><term>MAF</term><def><p>Minor allele frequency</p></def></def-item><def-item><term>NA</term><def><p>Not applicable</p></def></def-item><def-item><term>NCI</term><def><p>National cancer institute</p></def></def-item><def-item><term>NHANES</term><def><p>National health and nutrition examination survey</p></def></def-item><def-item><term>NHL</term><def><p>Non-Hodgkin lymphoma</p></def></def-item><def-item><term>OR</term><def><p>Odds ratio</p></def></def-item><def-item><term>SEER</term><def><p>Surveillance, epidemiology, and end results</p></def></def-item><def-item><term>SNP</term><def><p>Single nucleotide polymorphism</p></def></def-item><def-item><term>WT</term><def><p>Wild-type</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Electronic supplementary material</bold></p><p>The online version of this article (doi:10.1007/s10552-009-9348-5) contains supplementary material, which is available to authorized users.</p></fn></fn-group></back></article> 